Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FQWXA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,582
Award facts
- Contract value 100% obligated
- $14,582.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,582.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Cosentyx (secukinumab) 300 mg pen auto-injectors in 2 mL formulations. The contract, with an ultimate completion date of November 4, 2025, represents a non-competitive, non-set-aside procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement serving military and veteran healthcare systems through the Defense Health Agency and related government entities.
This delivery order is issued under AmerisourceBergen's SPE2DX master contract, a comprehensive $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical supplies across multiple therapeutic domains in support of military healthcare programs worldwide. The Cosentyx procurement supports immunological and rheumatological treatment needs within the defense medical supply chain, leveraging the established prime vendor relationship to fulfill federal healthcare requirements efficiently and cost-effectively.
Quick answers
Who was awarded contract SPE2DB26FQWXA?
SPE2DB26FQWXA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DB26FQWXA worth?
The government has obligated $14,582 on SPE2DB26FQWXA.
Is contract SPE2DB26FQWXA an order under another contract?
Yes. SPE2DB26FQWXA is a delivery order under SPE2DB25D3021, an indefinite delivery contract.
Was contract SPE2DB26FQWXA competed?
The extent of competition for SPE2DB26FQWXA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award